SEC Form 4 · accession 0001179110-18-014224

Teladoc Health, Inc. · TDOC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Dec 19, 2018

Accepted (ET)

Dec 21, 2018 · 4:00 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001477449

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Dec 19, 2018	M	30,000	$1.07	A	536,184	D
Common Stock^F1,F2	Dec 19, 2018	S	30,000	$49.55	D	506,184	D
Common Stock	Dec 20, 2018	M	31,870	$1.07	A	538,054	D
Common Stock	Dec 20, 2018	M	22,401	$1.67	A	560,455	D
Common Stock	Dec 20, 2018	M	9,988	$1.67	A	570,443	D
Common Stock	Dec 20, 2018	M	33,276	$6.01	A	603,719	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F3	$1.07	Dec 19, 2018	M	30,000	D	—	Apr 16, 2022	Common Stock	30,000	90,026	D
Employee Stock Option (right to buy)^F3	$1.07	Dec 20, 2018	M	31,870	D	—	Apr 16, 2022	Common Stock	31,870	58,156	D
Employee Stock Option (right to buy)^F4	$1.67	Dec 20, 2018	M	22,401	D	—	Dec 11, 2023	Common Stock	22,401	67,205	D
Employee Stock Option (right to buy)^F5	$1.67	Dec 20, 2018	M	9,988	D	—	Dec 11, 2023	Common Stock	9,988	79,618	D
Employee Stock Option (right to buy)^F6	$6.01	Dec 20, 2018	M	33,276	D	—	Dec 22, 2024	Common Stock	33,276	122,243	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018.
F2Represents the weighted average price of transactions ranging from $49.26 to $50.24. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3The option vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016.
F4The option vested as to 25% of the shares on January 1, 2015 The remainder of the shares vested or will vest in 30 equal monthly installments thereafter.
F5The option vested as to 25% of the shares on January 1, 2016. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter.
F6The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter.